Neuraxis annual return on equity
2024
2025
Neuraxis Return on Equity (ROE) Growth & History (NRXS)
Neuraxis's return on equity was −285.36% for fiscal 2025.
View full Neuraxis company overviewNeuraxis annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −285.36% | +2195.12 pp |
| 2024 | 2024-12-31 | −2,480.49% | — |
Neuraxis quarterly return on equity
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −33.42% | +41.52 pp |
| Q1 2026 | 2026-03-31 | −38.51% | +157.40 pp |
| Q4 2025 | 2025-12-31 | −60.12% | +997.46 pp |
| Q3 2025 | 2025-09-30 | −64.93% | — |
| Q2 2025 | 2025-06-30 | −74.93% | — |
| Q1 2025 | 2025-03-31 | −195.91% | — |
| Q4 2024 | 2024-12-31 | −1,057.58% | — |
Neuraxis return on equity trends
Between the periods ended 2024-12-31 and 2025-12-31, Neuraxis's return on equity increased from −2,480.49% to −285.36%, a change of +2195.12 percentage points. The latest reported quarter, Q2 2026, shows −33.42%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Neuraxis source filings ↗